NVDA
52
-4
FMC
40
6
NWSA
65
2
ECL
59
5
GRMN
70
5
JNJ
47
3
SHW
73
8
FSLR
49
-5
AXP
74
3
GME
70
4
MSI
70
-3
VMC
62
5
UNH
63
4
LH
48
5
DUK
57
2
PNR
71
2
SWKS
55
5
FOX
48
-3
ED
52
4
SE
63
2
NVDA
52
-4
FMC
40
6
NWSA
65
2
ECL
59
5
GRMN
70
5
JNJ
47
3
SHW
73
8
FSLR
49
-5
AXP
74
3
GME
70
4
MSI
70
-3
VMC
62
5
UNH
63
4
LH
48
5
DUK
57
2
PNR
71
2
SWKS
55
5
FOX
48
-3
ED
52
4
SE
63
2
Financhill
Back

IDEXX Laboratories Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

IDXX
IDEXX Laboratories

Last Price:
417.21
Seasonality Move:
7.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

IDEXX Laboratories Price Quote

$417.21
-11.38 (-2.66%)
(Updated: November 26, 2024 at 5:55 PM ET)

IDEXX Laboratories Key Stats

Sell
50
IDEXX Laboratories (IDXX) is a Sell
Day range:
$421.76 - $430.88
52-week range:
$398.50 - $583.39
Dividend yield:
0%
P/E ratio:
42.60
P/S ratio:
9.32
P/B ratio:
21.69%
Volume:
1.1M
Avg. volume:
762.2K
1-year change:
-10.37%
Market cap:
$35.1B
Revenue:
$3.7B
EPS:
$10.37

How Much Does IDEXX Laboratories Make?

Is IDEXX Laboratories Growing As A Company?

  • What Is IDEXX Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.11%

IDEXX Laboratories Stock Price Performance

What Is IDEXX Laboratories 52-Week High & Low?

IDEXX Laboratories Price To Free Cash Flow

Is It Risky To Buy IDEXX Laboratories?

  • How Much Debt Does IDEXX Laboratories Have?
    Total long term debt quarterly is $873.9M
  • How Much Cash Does IDEXX Laboratories Have?
    Cash and short term investments quarterly total is $308.6M
  • What Is IDEXX Laboratories’s Book Value Per Share?
    Book value per share is 19.72

Is IDEXX Laboratories Cash Flow Positive?

  • What Is IDXX Cash Flow From Operations?
    Cash flow from operations (TTM) is $916.8M
  • What Is IDEXX Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$747.1M
  • What Is IDEXX Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$197.7M

IDEXX Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    IDXX return on invested capital is 35.27%
  • What Is IDEXX Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 26.31%
  • What Is IDXX Return On Equity?
    ROE is a measure of profitability and is 57.37%

IDEXX Laboratories Earnings Date & Stock Price

IDEXX Laboratories Competitors

  • Who Are IDEXX Laboratories's Competitors?
    Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
    • Bio-Rad Laboratories Inc (BIO)
    • Boston Scientific Corp (BSX)
    • Haemonetics Corp (HAE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Stryker Corp (SYK)

IDEXX Laboratories Dividend Yield

IDEXX Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 10.67% 4.26%
Revenue: 6.56% -0.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 476.76
Upside from Last Price: 11.24%

Major Shareholders

  • How many IDXX shares are owned by institutional investors?
    124.1M IDXX shares are owned by institutional investors
  • How many IDXX shares are owned by insiders?
    716.5K IDXX shares are owned by insiders